Locana is developing 

a portfolio of RNA-targeting gene therapies

A flexible means to precisely treat

a range of human genetic diseases

Locana has a versatile platform technology with the potential to correct the underlying causes of human genetic disease.


Locana is actively engaged in partnering discussions to extend the capabilities of our platform, facilitate rapid advancement of our internal pipeline programs, and expand into additional disease areas.

Please contact bd@locanabio.com regarding any business development opportunities.

We have partnered with the Muscular Dystrophy Association to advance our development program for muscular dystrophy.

3545 John Hopkins Court Suite 200

San Diego, CA 92121


© 2019 LOCANA     , Inc.

All rights reserved.